At a glance
- Originator Astellas Pharma
- Class Anti-ischaemics; Anticoagulants; Pyrazoles; Pyridines; Small molecules
- Mechanism of Action Cytokine inhibitors; P38 mitogen-activated protein kinase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Reperfusion injury; Septic shock